BLUENERGIES LTD (BLU.CA) Stock Price, Quote, News and Overview
TSX:BLU - Toronto Stock Exchange - CA0959221007 - Common Stock - Currency: CAD
BLU.CA Quote, Performance and Key Statistics
TSX:BLU (4/30/2025, 7:00:00 PM)
0.44
-0.06 (-12%)
The current stock price of BLU.CA is 0.44 CAD.
BLU.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EDT.CA | SPECTRAL MEDICAL INC | N/A | 236.65M | ||
| FRX.CA | FENNEC PHARMACEUTICALS INC | N/A | 235.89M | ||
| EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 197.53M | ||
| TH.CA | THERATECHNOLOGIES INC | N/A | 176.56M | ||
| MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 81.35M | ||
| MSCL.CA | SATELLOS BIOSCIENCE INC | N/A | 68.23M | ||
| COV.CA | COVALON TECHNOLOGIES LTD | 13.94 | 64.99M | ||
| ONC.CA | ONCOLYTICS BIOTECH INC | N/A | 58.41M | ||
| MBX.CA | MICROBIX BIOSYSTEMS INC | 39.5 | 55.71M | ||
| SVA.CA | SERNOVA BIOTHERAPEUTICS INC | N/A | 53.76M | ||
| HBP.CA | HELIX BIOPHARMA CORP | N/A | 50.90M | ||
| BCT.CA | BRIACELL THERAPEUTICS CORP | N/A | 35.93M |
Related stock screener links
About BLU.CA
Company Profile
BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. The company is headquartered in Laval, Quebec and currently employs 74 full-time employees. The company went IPO on 2000-06-22. The firm's lead product candidate, BLU-5937, which is a selective, small molecule antagonist of the P2X3 receptor, as an oral therapy to reduce cough frequency in RCC patients. The firm has completed the BLUEPRINT clinical trial, a Phase II trial evaluating BLU-5937 in patients with chronic pruritus associated with AD. The firm is focused on initiating Phase III program. The firm is exploring the use of BLU-5937 in other patient populations experiencing cough hypersensitivity as well as other P2X3-related hypersensitization conditions.
Company Info
BLUENERGIES LTD
275 Armand-Frappier Blvd
Laval QUEBEC H7V 4A7 CA
CEO: Roberto Bellini
Employees: 74
Phone: 14506804500.0
BLUENERGIES LTD / BLU.CA FAQ
What is the stock price of BLUENERGIES LTD today?
The current stock price of BLU.CA is 0.44 CAD. The price decreased by -12% in the last trading session.
What is the ticker symbol for BLUENERGIES LTD stock?
The exchange symbol of BLUENERGIES LTD is BLU and it is listed on the Toronto Stock Exchange exchange.
On which exchange is BLU.CA stock listed?
BLU.CA stock is listed on the Toronto Stock Exchange exchange.
What is BLUENERGIES LTD worth?
BLUENERGIES LTD (BLU.CA) has a market capitalization of 55.79M CAD. This makes BLU.CA a Micro Cap stock.
How many employees does BLUENERGIES LTD have?
BLUENERGIES LTD (BLU.CA) currently has 74 employees.
Should I buy BLUENERGIES LTD (BLU.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BLU.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BLU.CA, evaluating the profitability, health, valuation and growth aspects
- BLUENERGIES LTD (BLU.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BLUENERGIES LTD (BLU.CA) Sales and EPS estimates to see what analysts future expectations are.
- BLUENERGIES LTD (BLU.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BLUENERGIES LTD (BLU.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- BLUENERGIES LTD (BLU.CA) Stock Chart to make your own analysis
- BLUENERGIES LTD (BLU.CA) Latest news and press-releases to stay up to date.
Does BLUENERGIES LTD (BLU.CA) stock pay dividends?
BLU.CA does not pay a dividend.
When does BLUENERGIES LTD (BLU.CA) report earnings?
BLUENERGIES LTD (BLU.CA) will report earnings on 2022-02-24.
BLU.CA Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to BLU.CA.
BLU.CA Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
BLU.CA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 76% to BLU.CA. The Buy consensus is the average rating of analysts ratings from 10 analysts.